OpenAlex
PricingAboutJobs
Log inGet started
Work

Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors

HTML

Year: 2018
Type: book-chapter
Source: Resistance to targeted anti-cancer therapeutics
Parent work: Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
DOI: 10.1007/978-3-319-67932-7_8
Author: Wolf Ruprecht Wiedemeyer
Institution: Cedars-Sinai Medical Center
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cyclin-dependent kinase inhibitors, CDK4/6 inhibitors, acquired drug resistance, palbociclib, ribociclib, abemaciclib, dinaciclib, hormone receptor-positive breast cancer, estrogen receptor-positive breast cancer, MAPK signaling, PI3K signaling, RB1 mutation, cell cycle dysregulation, combination therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2795296107
FWCI: 2.195
Cites: 133
Cited by: 10
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security